Patents by Inventor Jean-Francois Floch

Jean-Francois Floch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR ASSESSING THE RISK OF CANCER OCCURRENCE
    Publication number: 20210373027
    Abstract: The present invention provides a method for evaluating the risk of occurrence of cancer in an individual.
    Type: Application
    Filed: August 9, 2021
    Publication date: December 2, 2021
    Applicant: Syncerus S.À R.L.
    Inventor: Jean-Francois Floch
  • Compositions and methods for assessing the risk of cancer occurrence
    Patent number: 11085924
    Abstract: The present invention provides a method for evaluating the risk of occurrence of cancer in an individual.
    Type: Grant
    Filed: January 2, 2017
    Date of Patent: August 10, 2021
    Assignee: Syncerus S.À. R.L.
    Inventor: Jean-Francois Floch
  • RADIOLABELED PROGASTRIN IN CANCER DIAGNOSIS
    Publication number: 20200390913
    Abstract: The present invention provides a radiotracer comprising a progastrin moiety, a chelating moiety and a radioisotope. Uses of said biomarker for imaging and detecting cancers in a subject are also provided. In one embodiment, the radiotracer is 68Ga-NODAGA-Progastrin.
    Type: Application
    Filed: December 10, 2018
    Publication date: December 17, 2020
    Applicant: ECS-Biotracker SÀRL
    Inventor: Jean-François Floch
  • COMPOSITIONS AND METHODS FOR ASSESSING THE RISK OF CANCER OCCURRENCE
    Publication number: 20190011452
    Abstract: The present invention provides a method for evaluating the risk of occurrence of cancer in an individual.
    Type: Application
    Filed: January 2, 2017
    Publication date: January 10, 2019
    Applicant: Syncerus S.À R.L.
    Inventor: Jean-Francois Floch
  • Progastrin and liver pathologies
    Patent number: 8900817
    Abstract: Progastrin levels are determined to diagnose one or more liver pathologies.
    Type: Grant
    Filed: January 4, 2011
    Date of Patent: December 2, 2014
    Assignee: Les Laboratories Servier
    Inventors: Jean-François Floch, Leïla Houhou
  • Methods for treating breast cancer
    Patent number: 8900588
    Abstract: The present disclosure is directed to methods of treating and preventing breast cancer or recurrence of breast cancer with compositions comprising anti-progastrin antibodies.
    Type: Grant
    Filed: January 4, 2011
    Date of Patent: December 2, 2014
    Assignees: Les Laboratories Servier, Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS)
    Inventors: Jean-François Floch, Leïla Houhou, Françoise Cailler, Dominique Joubert, Frédéric Hollande
  • PROGASTRIN AND LIVER PATHOLOGIES
    Publication number: 20110229488
    Abstract: Progastrin levels are determined to diagnose one or more liver pathologies.
    Type: Application
    Filed: January 4, 2011
    Publication date: September 22, 2011
    Inventors: Jean-François Floch, Leïla Houhou
  • METHODS FOR TREATING BREAST CANCER
    Publication number: 20110177062
    Abstract: The present disclosure is directed to methods of treating and preventing breast cancer or recurrence of breast cancer with compositions comprising anti-progastrin antibodies.
    Type: Application
    Filed: January 4, 2011
    Publication date: July 21, 2011
    Inventors: Jean-François Floch, Leïla Houhou, Françoise Cailler, Dominique Joubert, Frédéric Hollande